BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16237810)

  • 1. Fatty liver and drugs.
    Grieco A; Forgione A; Miele L; Vero V; Greco AV; Gasbarrini A; Gasbarrini G
    Eur Rev Med Pharmacol Sci; 2005; 9(5):261-3. PubMed ID: 16237810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced steatohepatitis.
    Stravitz RT; Sanyal AJ
    Clin Liver Dis; 2003 May; 7(2):435-51. PubMed ID: 12879993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs and steatohepatitis.
    Farrell GC
    Semin Liver Dis; 2002; 22(2):185-94. PubMed ID: 12016549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological patterns in drug-induced liver disease.
    Ramachandran R; Kakar S
    J Clin Pathol; 2009 Jun; 62(6):481-92. PubMed ID: 19474352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].
    Dray X; Tainturier MH; De La Lande P; Marty O; Mallet L
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1122-3. PubMed ID: 11139682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
    Raja K; Thung SN; Fiel MI; Chang C
    Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced hepatic steatosis.
    Amacher DE; Chalasani N
    Semin Liver Dis; 2014 May; 34(2):205-14. PubMed ID: 24879984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.
    Bruno S; Maisonneuve P; Castellana P; Rotmensz N; Rossi S; Maggioni M; Persico M; Colombo A; Monasterolo F; Casadei-Giunchi D; Desiderio F; Stroffolini T; Sacchini V; Decensi A; Veronesi U
    BMJ; 2005 Apr; 330(7497):932. PubMed ID: 15746106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.
    Murata Y; Ogawa Y; Saibara T; Nishioka A; Takeuchi N; Kariya S; Onishi S; Yoshida S
    Oncol Rep; 2003; 10(1):97-100. PubMed ID: 12469151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-induced NASH].
    Saibara T; Onishi S
    Nihon Rinsho; 2006 Jun; 64(6):1100-5. PubMed ID: 16768116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic review of drug-induced steatohepatitis.
    Schumacher JD; Guo GL
    Toxicol Appl Pharmacol; 2015 Nov; 289(1):40-7. PubMed ID: 26344000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.
    Murata Y; Ogawa Y; Saibara T; Nishioka A; Fujiwara Y; Fukumoto M; Inomata T; Enzan H; Onishi S; Yoshida S
    Oncol Rep; 2000; 7(6):1299-304. PubMed ID: 11032933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic steatohepatitis.
    Saibara T; Onishi S; Ogawa Y; Yoshida S; Enzan H
    Lancet; 1999 Oct; 354(9186):1299-300. PubMed ID: 10520659
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen-induced transient multifocal hepatic fatty infiltration.
    Cai Q; Bensen M; Greene R; Kirchner J
    Am J Gastroenterol; 2000 Jan; 95(1):277-9. PubMed ID: 10638597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced Nonalcoholic Steatohepatitis].
    Miyamura M; Yokota J; Saibara T
    Yakugaku Zasshi; 2016; 136(4):579-82. PubMed ID: 27040342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease.
    Rabinowich L; Shibolet O
    Biomed Res Int; 2015; 2015():168905. PubMed ID: 26273591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist.
    Ahmed MH; Osman KA
    Breast Cancer Res Treat; 2006 May; 97(2):223-4. PubMed ID: 16322887
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
    López-Pascual E; Rienda I; Perez-Rojas J; Rapisarda A; Garcia-Llorens G; Jover R; Castell JV
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug induced hepatitis mimicking alcoholic hepatitis].
    Kang DY; Jin SY
    Korean J Hepatol; 2006 Dec; 12(4):574-8. PubMed ID: 17237637
    [No Abstract]   [Full Text] [Related]  

  • 20. [Steatosis and nonalcoholic steatohepatitis. A comparative analysis].
    Piñol V; Bessa X; Bruguera M; Rodés J
    Gastroenterol Hepatol; 2000 Feb; 23(2):57-61. PubMed ID: 10726383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.